Skip to content
healthcare.dev

Neostigmine Methylsulfate

NDC 43598-945, Neostigmine Methylsulfate, injection, solution, from Dr.Reddys Laboratories Inc.

Product NDC
43598-945
Status
Listed
Labeler
Dr.Reddys Laboratories Inc
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216291
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43598-945 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE1 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
43598-945-584359809455810 BLISTER PACK in 1 CARTON (43598-945-58) / 1 SYRINGE, GLASS in 1 BLISTER PACK (43598-945-11) / 3 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/12575d1a-a2c2-37b2-0dcf-31e58bbc2a10

Use it

Look up 43598-945 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43598-945 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43598-945. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.